Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katarzyna Marcisz-Grzanka
Observed name:
K. Marcisz-Grzanka
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0001-7200-2070
Observed ORCID:
0000-0001-7200-2070
OpenAlex ID:
A5003220156
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients
2024
·
Katarzyna Marcisz-Grzanka
, Beata Kotowicz
, et al.
·
Cancers
·
6
PDF
Eligibility criteria in phase 3 randomized controlled trials in gastric cancer
2025
·
Katarzyna Marcisz-Grzanka
, Danuta Kłosowska
, et al.
·
Gastric Cancer
·
4
PDF
P-341 Tumor regression and nodal status to neoadjuvant chemotherapy as a prognostic marker in patients with locally advanced gastric and gastroesophageal cancer
2023
·
K. Marcisz-Grzanka
, S. Rybski
, et al.
·
Annals of Oncology
·
2
PDF
Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial
2022
·
Katarzyna Marcisz-Grzanka
, Mariola Winiarek
, et al.
·
Neoplasma
·
2
PDF
1440P Safety and efficacy of FLOT regimen neoadjuvant treatment in Polish population: Interim analysis of prospective biomarker study
2020
·
K. Marcisz-Grzanka
, M. Winiarek
, et al.
·
Annals of Oncology
·
1
648eTiP Prospective, multicentre evaluation of interleukin-6 and ctDNA as a predictive factor of pathological response to FLOT/D-FLOT regimen systemic treatment in locally advanced gastric cancer (GC) or gastroesophageal junction (GEJ) cancer patients (PRE-D-FLOT6)
2026
·
K. Marcisz-Grzanka
, M. Winiarek
, et al.
·
Annals of Oncology
PDF
566P Randomized, prospective study of the impact of microjejunostomy after gastrectomy (PROMIGA study): Impact on adjuvant chemotherapy administration
2026
·
K. Marcisz-Grzanka
, M. Gaciong
, et al.
·
Annals of Oncology
PDF
Sarcopenia measured radiographically as a prognostic and predictive factor of response to perioperative FLOT regimen chemotherapy in gastric cancer patients.
2026
·
Katarzyna Marcisz-Grzanka
, Michalina Wach-Maslon
, et al.
·
Journal of Clinical Oncology
434eP Eligibility criteria in phase III randomized controlled trials in stomach cancer
2025
·
J. Borysowski
, K. Marcisz-Grzanka
, et al.
·
Annals of Oncology
Long-term outcomes of total neoadjuvant treatment (TNT) for locally advanced rectal cancer: Maria Sklodowska Curie National Cancer Research Institute (MSCNCRI) cohort from Polish-II study.
2025
·
Mariola Winiarek
, Katarzyna Marcisz-Grzanka
, et al.
·
Journal of Clinical Oncology
PDF
1201P Evaluation of efficacy TEMCAP regiment as first-line or further line therapy in patients with advanced, unresectable, progressive GEP-NET. Real-world data
2023
·
A.D. Kolasinska-Cwikla
, J. Cwikla
, et al.
·
Annals of Oncology
PDF
IL-1β and IL-6 as predictors of ypN and early response to neoadjuvant chemotherapy in patients with locally advanced GC and GEJ cancer.
2023
·
Katarzyna Marcisz-Grzanka
, Małgorzata Fuksiewicz
, et al.
·
Journal of Clinical Oncology
P-256 Efficacy of FLOT regimen in the Polish population – real-world data from a prospective biomarker study
2022
·
K. Marcisz-Grzanka
, M. Winiarek
, et al.
·
Annals of Oncology
P-270 Updated results of Maria Sklodowska-Curie National Research Institute of Oncology gastric cancer cohort: Indirect comparison between adjuvant chemoradiation and perioperative chemotherapy in gastric cancer patients
2022
·
M. Mydlowska
, S. Rybski
, et al.
·
Annals of Oncology
Long-term observation of gastric patients with positive immunocytochemistry of peritoneal washing
2021
·
Katarzyna Marcisz-Grzanka
, Paulina Wieszczy
, et al.
·
Neoplasma
PDF
A phase II study of avelumab in MSI-H metastatic colorectal cancer patients - Trial in progress
2018
·
D. Proszynski
, M. Winiarek
, et al.
·
Annals of Oncology
Long-term survival of gastric cancer patients with positive immunocytochemistry peritoneal washings.
2018
·
Katarzyna Marcisz-Grzanka
, Paulina Wieszczy
, et al.
·
Journal of Clinical Oncology
Phase II randomized study of two oxaliplatin and 5-fluorouracil regimens in the second line palliative chemotherapy of metastatic pancreatic cancer patients (MazoviaGI-1)
2017
·
Dawid Proszynski
, Agnieszka Kolasinska-Cwikła
, et al.
·
Annals of Oncology
PDF
The role of serum tumour markers, inflammation-based markers and circulating tumour cells as surrogate biomarkers of early response to neoadjuvant systemic treatment in patients with resectable gastric cancer.
2017
·
Katarzyna Marcisz-Grzanka
, Tomasz Olesinski
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
19
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type